NCT00464932View on ClinicalTrials.gov

Vasoactive Intestinal Peptide in COPD

CompletedOBSERVATIONAL

Enrollment

34

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

July 31, 2006

Conditions

COPDPulmonary Hypertension

Interventions

DRUG

Vasoactive Intestinal Peptide (VIP)

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT00464932 - Vasoactive Intestinal Peptide in COPD | Biotech Hunter | Biotech Hunter